Skip to main content

John H. Rundback, MD, FAHA, FSIR

Case Report
11/08/2024
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been...
11/08/2024
Vascular Disease Management
Drs Rundback and Wiechmann
Podcast
01/25/2023
A discussion with Dr. Bret Wiechmann and Dr. John Rundback.
A discussion with Dr. Bret Wiechmann and Dr. John Rundback.
A discussion with Dr. Bret...
01/25/2023
Vascular Disease Management
Dr Rundback
ISET 2023
02/09/2023
Watch as Interventional Radiologist Dr. John Rundback describes his presentation on duplex findings after deep venous arterialization at ISET 2023.
Watch as Interventional Radiologist Dr. John Rundback describes his presentation on duplex findings after deep venous arterialization at ISET 2023.
Watch as Interventional...
02/09/2023
Vascular Disease Management
04/18/2014
Abstract: Purpose: The purpose of this study was to analyze outcomes in a single-center cohort of patients undergoing CT-guided percutaneous renal radiofrequency ablation (rRFA) to determine if lesion size was a differentiator of outcomes,...
Abstract: Purpose: The purpose of this study was to analyze outcomes in a single-center cohort of patients undergoing CT-guided percutaneous renal radiofrequency ablation (rRFA) to determine if lesion size was a differentiator of outcomes,...
Abstract: Purpose: The purpose...
04/18/2014
IO Learning
Rundback
Video
04/06/2023
Dr. Rundback, an interventional radiologist, showcases the telescoping feature and hydrophilic coating of the NEW ViperCross™ Support Catheter for PAD interventions.
Dr. Rundback, an interventional radiologist, showcases the telescoping feature and hydrophilic coating of the NEW ViperCross™ Support Catheter for PAD interventions.
Dr. Rundback, an interventional...
04/06/2023
Vascular Disease Management
09/11/2013
  Primary non-small cell lung cancer (NSCLC) causes more deaths in the United States per year than the combined mortality of breast, colon, and prostate cancer.1 For newly diagnosed patients, the 5-year overall survival rate is 15%. Due...
  Primary non-small cell lung cancer (NSCLC) causes more deaths in the United States per year than the combined mortality of breast, colon, and prostate cancer.1 For newly diagnosed patients, the 5-year overall survival rate is 15%. Due...
  Primary non-small cell...
09/11/2013
IO Learning
OBL Corner
01/31/2022
VDM profiles Dr. John Rundback and his OBL, American Endovascular & Amputation Prevention, in West Orange, NJ.
VDM profiles Dr. John Rundback and his OBL, American Endovascular & Amputation Prevention, in West Orange, NJ.
VDM profiles Dr. John Rundback...
01/31/2022
Vascular Disease Management
CLI Perspectives
01/08/2016
Critical limb ischemia (CLI) therapy is experiencing immense growth and it is reflected among all specialties. Most of the growth is in the form of endovascular therapies. Despite this vast growth in therapy, the outcome and results are not...
Critical limb ischemia (CLI) therapy is experiencing immense growth and it is reflected among all specialties. Most of the growth is in the form of endovascular therapies. Despite this vast growth in therapy, the outcome and results are not...
Critical limb ischemia (CLI)...
01/08/2016
Cath Lab Digest
Video
09/14/2022
Drs. Wiechmann and Rundback discuss the role of OBLs in treating advanced vascular disease and CLI, and talk about how OEIS serves the outpatient endovascular community.
Drs. Wiechmann and Rundback discuss the role of OBLs in treating advanced vascular disease and CLI, and talk about how OEIS serves the outpatient endovascular community.
Drs. Wiechmann and Rundback...
09/14/2022
Vascular Disease Management
Vascular Disease
01/11/2010
“EVAR is the preferred treatment for ruptured aneurysms.” Frank J. Veith, MD, Professor of Surgery, The Cleveland Clinic and New York University, The William J. von Liebig Chair in Vascular Surgery, The Cleveland Clinic and New York...
“EVAR is the preferred treatment for ruptured aneurysms.” Frank J. Veith, MD, Professor of Surgery, The Cleveland Clinic and New York University, The William J. von Liebig Chair in Vascular Surgery, The Cleveland Clinic and New York...
“EVAR is the preferred treatment...
01/11/2010
Cath Lab Digest